Newlink Genetics reported $-7251000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Agenus AGEN:US USD -54222000 7.79M
Bristol Myers Squibb BMY:US USD 2.02B 416M
Eli Lilly And LLY:US USD 1.94B 486M
Idera Pharmaceuticals IDRA:US USD -3099000 2.21M
Intrexon XON:US USD 87.38M 105.01M
Merk MRK:US USD 3.02B 231M
Nektar Therapeutics NKTR:US USD -59049000 100.02M
Newlink Genetics NLNK:US USD -7251000 593K
Pfizer PFE:US USD 5B 3.61B
Prothena PRTA:US USD -45764000 4.52M
Sarepta Therapeutics SRPT:US USD -257738000 26.26M
Vascular Biogenics VBLT:US USD -9170000 264K